Sudienerfahrung / Laufende Studien / Publikationen

STUDIENERFAHRUNG Funktion: Site Principal Investigator
Start Date Study Phase Indication
1993 IBCSG 13-93 III Breast Cancer
1993 IBCSG 14-93 III Breast Cancer
1998 SAKK 44/00 III Follicular of Mantle Cell Lymphoma
2000 SAKK ICON 3 III Advanced Pancreatic Cancer
2002 SAKK 35/98 III Breast Cancer
2006 SAKK 24/06 II Breast Cancer
2006 HD10-12 III Colorectal Cancer
2007 IBCSG BIG-1 III Breast Cancer
2007 SAKK CML III A II Prostate Cancer
2007 SAKK CML III A II Prostate Cancer

AKTUELL LAUFENDE STUDIEN
Funktion: Site Principal Investigator
SAKK 08/07
SAKK 41/06
IBCSG 35-07
IBCSG 24-02
IBCSG 22-00
START
Funktion: Principal Investigator in Switzerland
STRIDE

PUBLIKATIONEN

Monoclonal antibody SEN7 recognizes a new epitope on the neural cell adhesion Molecule present on small cell lung cancer but not on lymphocytes.
Waibel R, Mannhart M, O'Hara CJ, Brocklehurst C, Zangemeister-Wittke U, Schenker T, Lehmann HP, Weber E, Stahel RA.
Cancer Res. 1993 Jun 15;53(12):2840-5.

M. Rabaglio, Z. Sun, K. N. Price, M. Castiglione-Gertsch, H. Hawle, B. Thürlimann, H. Mouridsen, M. Campone, J. F. Forbes, R. J. Paridaens, M. Colleoni, T. Pienkowski, J.-M. Nogaret, I. Láng, I. Smith, R. D. Gelber, A. Goldhirsch, A. S. Coates, and for the BIG 1-98 Collaborative and International Breast Cancer Study Groups
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial Ann. Onc., Advance Access published on May 27, 2009; doi: doi:10.1093/annonc/mdp033
......Limmattalspital, Schlieren: N. Burki; Private Praxis, Birsfelden: A. Dieterle; Private Praxis, Biel: L. Hasler; Private Praxis, Baar: M. Mannhart-Harms; Brust-Zentrum, Zurich: C. Rageth; Private Praxis, Berne: J. Richner; Private Praxis, Bellinzona: V. Spataro; Private......

Onkologie
International Journal for Cancer Research and Treatment
Vol. 22, No. 3, 1999
Casuistic Contribution • Kasuistik Papillary Thyroid Carcinoma in an Adult Teratoma in Combination with Mucinous Cystadenoma of the Ovary
M. Mannhart-Harms, P.A. Diener, B. Thürlimann, R. Urscheler

ECCO 2009 Abstract PD-5019:
Pegylated liposomal doxorubicin and Bevacizumab as first-line therapy for locallyrecurrent or metastatic breast cancer - a multicenter, single-arm phase II trial of the Swiss Group for Clinical Cancer Research (SAKK)
C. Rochlitz; R. Von Moos; M. Mannhart-Harms; R. Winterhalder; D. Rauch; A. Muller; K. Zaman; S. Lerch; M. Mayer; F. Zappa

KREBSSTRATEGIE 2010-2015 DES KANTONS ZUG

• European Society for Medical Oncology (ESMO) American Society of Clinical Oncology (ASCO) Schweizerische Gesellschaft für Medizinische Onkologie (SGMO) Swiss Tumor Institute (STI), Vorstand Krebsliga Zug, Vorstand Spezialärztevereinigung des Kantons Zug, Präsident

• Deutsch
• Englisch

• Mibs und Mabs oder neue onkologische Therapien
• Forum 1/2010
• Forum 1/2009
• Krebs - Wissen fördert die Heilung
• Brustkrebs: Therapie und Nachsorge